Multivac-9
Multivac-9
Authorised
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type B, epsilon toxoid
- Clostridium novyi, toxoid
- Clostridium septicum, toxoid
- Clostridium tetani, toxoid
- Clostridium sordellii, toxoid
- Clostridium chauvoei, Inactivated
Product identification
Medicine name:
Multivac-9
Active substance:
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type B, epsilon toxoid
- Clostridium novyi, toxoid
- Clostridium septicum, toxoid
- Clostridium tetani, toxoid
- Clostridium sordellii, toxoid
- Clostridium chauvoei, Inactivated
Target species:
-
Cattle
-
Goat
-
Sheep
-
Pig
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium perfringens, type A, alpha toxoid1.00international unit(s)/millilitre2.00millilitre(s)
-
Clostridium perfringens, type C, beta toxoid10.00international unit(s)/millilitre2.00millilitre(s)
-
Clostridium perfringens, type B, epsilon toxoid5.00international unit(s)/millilitre2.00millilitre(s)
-
Clostridium novyi, toxoid3.50international unit(s)/millilitre2.00millilitre(s)
-
Clostridium septicum, toxoid2.50international unit(s)/millilitre2.00millilitre(s)
-
Clostridium tetani, toxoid2.50international unit(s)/millilitre2.00millilitre(s)
-
Clostridium sordellii, toxoid100.00percentage protection2.00millilitre(s)
-
Clostridium chauvoei, Inactivated90.00percentage protection2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
Meat and offal0day
-
- Goat
-
Meat and offal0day
-
- Sheep
-
Meat and offal0day
-
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Available in:
-
Portugal
Package description:
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Saude Animal Produtos Farmaceuticos E Imunologicos Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
- Cz Veterinaria S.A.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 208/87 DGV
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 26/06/2023
How useful was this page?: